Overcoming Acquired Resistance to AZD9291, a Third Generation EGFR Inhibitor, Through Modulation of MEK/ERK-dependent Bim and McL-1 Degradation

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-17-1574
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

MET or NRAS Amplification Is an Acquired Resistance Mechanism to the Third-Generation EGFR Inhibitor Naquotinib

Scientific Reports
Multidisciplinary
2018English

Molecular Mechanisms of Acquired Resistance to Third-Generation EGFR-TKIs in EGFR T790m-Mutant Lung Cancer

Annals of Oncology
MedicineOncologyHematology
2019English

Acquired EGFR C797S Mutation Mediates Resistance to AZD9291 in Non–small Cell Lung Cancer Harboring EGFR T790M

Nature Medicine
BiochemistryMedicineGeneticsMolecular Biology
2015English

MA15.06 Circulating Tumor DNA Portrays the Resistance Landscape to a Novel Third Generation EGFR Inhibitor, AC0010

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

WZ4002, a Third-Generation EGFR Inhibitor, Can Overcome Anoikis Resistance in EGFR-mutant Lung Adenocarcinomas More Efficiently Than SRC Inhibitors

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2011English

NDRG2 Contributes to Cisplatin Sensitivity Through Modulation of BAK-to-Mcl-1 Ratio

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2018English

PAK Signaling Promotes Acquired Resistance to BRAF and MEK Inhibitors

Cancer Discovery
Oncology
2017English

RASSF1A Mediates P21Cip1/Waf1-Dependent Cell Cycle Arrest and Senescence Through Modulation of the Raf-Mek-Erk Pathway and Inhibition of Akt

Cancer Research
Cancer ResearchOncology
2009English

Phenylethyl Isothiocyanate Reverses Cisplatin Resistance in Biliary Tract Cancer Cells via Glutathionylation-Dependent Degradation of McL-1

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy